• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Anesthetic-induced myocardial conditioning: Molecular fundamentals and scope

Bioengineer by Bioengineer
December 26, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Jose Luis Guerrero Orriach et al. is published in Current Medicinal Chemistry, 2018

Many studies have shown that the mechanism of drug-induced myocardial conditioning is enzyme-mediated through messenger RNA and miRNA regulation. In this study Orriach et al. investigated the role that miRNAs play in the cardio-protective effect of halogenated anesthetics, which are widely used in cardiac surgery. The study includes a literature review of the expression profile of miRNAs in ischemic conditions and in the complications which were prevented by these phenomena.

To identify miRNAs involved in anesthetic-induced myocardial conditioning, a review was conducted of more than 100 studies. The expression is modulated by the perioperative administration of halogenated anesthetics. This is the first study of its kind.

For future research in the field of cardiology, the potential of miRNAs as biomarkers and miRNAs-based therapies involving the synthesis, inhibition or stimulation of miRNAs stand out as a promising avenue. The cardio-protective effects of myocardial conditioning are related to the expression of several miRNAs. New therapeutic and diagnostic opportunities come across as cumulative evidence of miRNAs playing a role in heart disease and myocardial conditioning is revealed. While further research is needed in this direction, these studies provide new grounds for the development of new hypnotic/anesthetic agents for cardiac surgery patients.

###

The article can be obtained from the following link: http://www.eurekaselect.com/165708

Media Contact
Faizan ul Haq
faizan@benthamscience.net
http://dx.doi.org/10.2174/0929867325666180926161427

Tags: BiochemistryBiotechnologyCardiologyCritical Care/Emergency MedicineHealth Care Systems/ServicesMedicine/HealthMolecular BiologyPharmaceutical ChemistryPharmaceutical ScienceStroke
Share12Tweet8Share2ShareShareShare2

Related Posts

Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)

September 18, 2025

Texas A&M Researchers Develop Innovative Cryopreservation Technique to Stop Organ Cracking

September 18, 2025

Optimizing Geriatric Care: Staff Insights on Patient Mobilization

September 18, 2025

Researchers Pinpoint Potential Therapeutic Targets in Pediatric Germ Cell Tumors

September 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)

Emerging Research Links Microplastics to Potential Risks for Bone Health

Early Universe Galaxies Unveil Hidden Dark Matter Maps

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.